Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

9.19
-0.0400-0.43%
Post-market: 9.190.00000.00%19:30 EDT
Volume:2K
Turnover:21.12K
Market Cap:60.47M
PE:-2.77
High:9.32
Open:9.32
Low:9.17
Close:9.23
52wk High:12.74
52wk Low:6.47
Shares:6.58M
Float Shares:3.40M
Volume Ratio:0.15
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3174
EPS(LYR):-15.2374
ROE:-55.03%
ROA:-13.61%
PB:0.84
PE(LYR):-0.60

Loading ...

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.d. to Its Board of Directors

THOMSON REUTERS
·
Apr 16

Press Release: Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Dow Jones
·
Apr 16

Insider Move at Xilio Therapeutics Sparks Fresh Investor Interest

TIPRANKS
·
Mar 31

Xilio director Shannon James Samuel buys USD 0.04 million common shares

Reuters
·
Mar 31

Xilio Therapeutics Inc : Leerink Partners Adjusts Target Price to $20 From $2 to Reflect 1-for-14 Reverse Stock Split

THOMSON REUTERS
·
Mar 24

Xilio Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker

Reuters
·
Mar 23

BUZZ-Xilio rises after surprise quarterly profit

Reuters
·
Mar 23

Xilio Therapeutics Inc: Q4 Net Income USD 10.36 Million

THOMSON REUTERS
·
Mar 23

Xilio Therapeutics posts Q4 profit on higher collaboration revenue

Reuters
·
Mar 23

Xilio Therapeutics Q4 license revenue rose 100% to USD 14 million, net income was USD 10 million

Reuters
·
Mar 23

Xilio Therapeutics Inc - Cash Runway Extended Through End of 2027

THOMSON REUTERS
·
Mar 23

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 23

Xilio Therapeutics to present XTX601 CLDN18.2 masked T cell engager data at AACR Annual Meeting

Reuters
·
Mar 18

Xilio Therapeutics Inc trading halted, news pending

TIPRANKS
·
Mar 14

Xilio Therapeutics to implement 1-for-14 reverse stock split March 13, 2026

Reuters
·
Mar 12

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split

THOMSON REUTERS
·
Mar 12

Xilio Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Mar 06

Xilio Therapeutics announces inducement grants

TIPRANKS
·
Mar 02

BRIEF-Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 02